用于心肌梗死治疗的脱细胞支架水凝胶材料：“母体”真的会是未来的方向吗？ - Suppr | 超能文献

Decellularized Scaffold Hydrogel Materials for MI Treatment: Could "The Matrix" Really Be the Future?

作者信息

Costa Kevin D

机构信息

Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, New York.

出版信息

J Am Coll Cardiol. 2016 Mar 8;67(9):1087-1090. doi: 10.1016/j.jacc.2016.01.006.

DOI:10.1016/j.jacc.2016.01.006

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Decellularized Scaffold Hydrogel Materials for MI Treatment: Could "The Matrix" Really Be the Future?用于心肌梗死治疗的脱细胞支架水凝胶材料：“母体”真的会是未来的方向吗？

J Am Coll Cardiol. 2016 Mar 8;67(9):1087-1090. doi: 10.1016/j.jacc.2016.01.006.

2

Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.心肌基质水凝胶用于心肌梗死后治疗功能益处的潜在机制证据。

J Am Coll Cardiol. 2016 Mar 8;67(9):1074-1086. doi: 10.1016/j.jacc.2015.12.035.

3

Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction.在细胞外基质衍生水凝胶中递送工程化肝细胞生长因子片段可预防心肌梗死后左心室不良重塑。

Biomaterials. 2015 Mar;45:56-63. doi: 10.1016/j.biomaterials.2014.12.021. Epub 2015 Jan 13.

4

Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.脱细胞心室细胞外基质衍生的可输送导管水凝胶可增加内源性心肌细胞并保留心肌梗死后的心脏功能。

J Am Coll Cardiol. 2012 Feb 21;59(8):751-63. doi: 10.1016/j.jacc.2011.10.888.

5

Decellularized heart ECM hydrogel using supercritical carbon dioxide for improved angiogenesis.使用超临界二氧化碳制备脱细胞心脏细胞外基质水凝胶以改善血管生成。

Acta Biomater. 2018 Feb;67:270-281. doi: 10.1016/j.actbio.2017.11.046. Epub 2017 Dec 6.

6

The effect of hydrogel injection on cardiac function and myocardial mechanics in a computational post-infarction model.水凝胶注射对心肌梗死后计算模型中心脏功能和心肌力学的影响。

Comput Methods Biomech Biomed Engin. 2013;16(11):1185-95. doi: 10.1080/10255842.2012.656611. Epub 2012 Mar 22.

7

Application of the HeartLander crawling robot for injection of a thermally sensitive anti-remodeling agent for myocardial infarction therapy.HeartLander爬行机器人在注射热敏抗重塑剂用于心肌梗死治疗中的应用。

Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:5428-31. doi: 10.1109/IEMBS.2010.5626518.

8

Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction.局部水凝胶释放重组 TIMP-3 可减轻实验性心肌梗死后的不良左心室重构。

Sci Transl Med. 2014 Feb 12;6(223):223ra21. doi: 10.1126/scitranslmed.3007244.

9

Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats.心肌内注射心脏组织衍生细胞外基质可改善大鼠梗死后心功能。

J Cardiovasc Pharmacol Ther. 2013 May;18(3):270-9. doi: 10.1177/1074248412472257. Epub 2013 Jan 22.

10

Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice.蛋白酪氨酸磷酸酶1B缺陷型小鼠心肌梗死后血管生成增强及心脏灌注增加。

FASEB J. 2014 Aug;28(8):3351-61. doi: 10.1096/fj.13-245753. Epub 2014 Apr 23.

引用本文的文献

1

Graphene Oxide-Gold Nanosheets Containing Chitosan Scaffold Improves Ventricular Contractility and Function After Implantation into Infarcted Heart.载壳聚糖支架的氧化石墨烯-金纳米片改善梗死心脏植入后的心室收缩性和功能。

Sci Rep. 2018 Oct 10;8(1):15069. doi: 10.1038/s41598-018-33144-0.

2

Global position paper on cardiovascular regenerative medicine.心血管再生医学全球立场文件。

Eur Heart J. 2017 Sep 1;38(33):2532-2546. doi: 10.1093/eurheartj/ehx248.